PT3395357T - Composição para simulação de ovário controlada - Google Patents

Composição para simulação de ovário controlada

Info

Publication number
PT3395357T
PT3395357T PT18167552T PT18167552T PT3395357T PT 3395357 T PT3395357 T PT 3395357T PT 18167552 T PT18167552 T PT 18167552T PT 18167552 T PT18167552 T PT 18167552T PT 3395357 T PT3395357 T PT 3395357T
Authority
PT
Portugal
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
PT18167552T
Other languages
English (en)
Inventor
Arce Joan-Carles
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3395357(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of PT3395357T publication Critical patent/PT3395357T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT18167552T 2011-08-08 2012-08-08 Composição para simulação de ovário controlada PT3395357T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08

Publications (1)

Publication Number Publication Date
PT3395357T true PT3395357T (pt) 2019-08-27

Family

ID=46785372

Family Applications (6)

Application Number Title Priority Date Filing Date
PT201869351T PT3756681T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT14184409T PT2821080T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada
PT18167552T PT3395357T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada
PT192136497T PT3646881T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT212077176T PT4005588T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT17154031T PT3195875T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PT201869351T PT3756681T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT14184409T PT2821080T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada

Family Applications After (3)

Application Number Title Priority Date Filing Date
PT192136497T PT3646881T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT212077176T PT4005588T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT17154031T PT3195875T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário

Country Status (31)

Country Link
US (4) US9694052B2 (pt)
EP (9) EP2821080B1 (pt)
JP (5) JP6161609B2 (pt)
KR (7) KR20200121918A (pt)
CN (2) CN103732243A (pt)
AR (1) AR087476A1 (pt)
AU (3) AU2012293647B2 (pt)
BR (2) BR112014002884A2 (pt)
CA (1) CA2844282A1 (pt)
CY (1) CY1117214T1 (pt)
DK (8) DK3195875T3 (pt)
ES (7) ES2704878T3 (pt)
FI (2) FI3756681T3 (pt)
HK (2) HK1204923A1 (pt)
HR (8) HRP20240420T1 (pt)
HU (7) HUE041769T2 (pt)
IL (2) IL300380A (pt)
JO (1) JO3092B1 (pt)
LT (7) LT3566712T (pt)
MX (2) MX348981B (pt)
PL (8) PL2821080T3 (pt)
PT (6) PT3756681T (pt)
RS (8) RS65485B1 (pt)
RU (2) RU2739037C3 (pt)
SA (1) SA112330762B1 (pt)
SI (8) SI3566712T1 (pt)
SM (1) SMT201600038B (pt)
TR (2) TR201900071T4 (pt)
TW (2) TWI555530B (pt)
WO (1) WO2013020996A1 (pt)
ZA (2) ZA201400952B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
CN107429237B (zh) * 2014-12-22 2021-09-28 豪夫迈·罗氏有限公司 Cmp依赖性的唾液酸酶活性
US10660938B2 (en) * 2015-04-17 2020-05-26 Ferring B.V. Recombinant FSH composition for treatment of infertility
RU2719468C2 (ru) 2015-06-26 2020-04-17 Ферринг Б.В. Способы очистки и/или вирусной инактивации
BR112018003455A2 (pt) * 2015-09-17 2018-09-25 Glycotope Gmbh composição ou composição farmacêutica e uso da composição
EP3518952A1 (en) 2016-09-30 2019-08-07 Myovant Sciences GmbH Methods of treating female infertility
BR112020003379A2 (pt) 2017-09-01 2020-08-25 Ferring B.V. usos de hormônio folículo-estimulante recombinante (fsh) para estimulação ovariana controlada
TW201945024A (zh) * 2018-04-30 2019-12-01 荷蘭商菲林公司 用於經控制之卵巢刺激的組成物
KR20210079276A (ko) 2018-10-17 2021-06-29 훼링 비.브이. 제어된 난소 자극을 위한 조성물 및 방법
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗多囊卵巢综合征中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
WO2023186331A1 (en) 2022-04-01 2023-10-05 Ferring B.V. Mixed protocol for treatment of infertility
WO2023227761A1 (en) 2022-05-26 2023-11-30 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2024008971A1 (en) 2022-07-08 2024-01-11 Ferring B.V. Compositions and methods for intrauterine insemination (iui)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122732A0 (en) 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
CA2464368A1 (en) * 2001-10-22 2003-05-01 Applied Research Systems Ars Holding N.V. Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) * 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) * 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
PL2621517T5 (pl) * 2010-09-29 2024-01-29 Ferring B.V. Kompozycja do stosowania w leczeniu niepłodności
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
HUE040058T2 (hu) 2019-02-28
DK3646881T3 (da) 2021-07-26
CA2844282A1 (en) 2013-02-14
PL3395357T3 (pl) 2019-11-29
TR201911269T4 (tr) 2019-08-21
SMT201600038B (it) 2016-02-25
MX2014001489A (es) 2014-04-25
HRP20210277T1 (hr) 2021-04-02
HUE053716T2 (hu) 2021-07-28
EP3646881B1 (en) 2021-04-28
HUE044610T2 (hu) 2019-11-28
LT3756681T (lt) 2023-07-25
JP6718951B2 (ja) 2020-07-08
EP3195875B1 (en) 2018-07-25
EP2741763B1 (en) 2015-11-18
KR20190100449A (ko) 2019-08-28
EP2821080A1 (en) 2015-01-07
RU2739037C3 (ru) 2021-09-08
RS61843B1 (sr) 2021-06-30
FI3756681T3 (fi) 2023-07-28
JP2017141253A (ja) 2017-08-17
LT2821080T (lt) 2019-01-10
HUE062640T2 (hu) 2023-11-28
IL230696B2 (en) 2023-07-01
PT4005588T (pt) 2024-04-24
US11291708B2 (en) 2022-04-05
RU2613324C3 (ru) 2021-06-09
JP7309660B2 (ja) 2023-07-18
MX348981B (es) 2017-07-06
PT3756681T (pt) 2023-07-25
RU2014102924A (ru) 2015-09-20
US20220370567A1 (en) 2022-11-24
NZ620369A (en) 2015-12-24
SI3646881T1 (sl) 2021-08-31
HUE041769T2 (hu) 2019-05-28
WO2013020996A1 (en) 2013-02-14
ZA201400952B (en) 2022-03-30
HUE054312T2 (hu) 2021-08-30
RS65485B1 (sr) 2024-05-31
ZA201506382B (en) 2017-01-25
CY1117214T1 (el) 2017-04-05
JP2019077693A (ja) 2019-05-23
PT3195875T (pt) 2018-10-31
US9694052B2 (en) 2017-07-04
RS57897B1 (sr) 2019-01-31
DK3756681T3 (da) 2023-07-31
MX2020010991A (es) 2020-11-09
TW201716082A (zh) 2017-05-16
HRP20191437T1 (hr) 2019-11-15
HK1198005A1 (zh) 2015-03-06
SA112330762B1 (ar) 2015-10-08
PT3646881T (pt) 2021-06-02
HRP20190023T1 (hr) 2019-02-22
RU2017106756A3 (pt) 2020-07-09
IL300380A (en) 2023-04-01
JP6500050B2 (ja) 2019-04-10
JP2020147600A (ja) 2020-09-17
JP2023134561A (ja) 2023-09-27
SI4005588T1 (sl) 2024-06-28
CN103732243A (zh) 2014-04-16
IL230696B1 (en) 2023-03-01
PT2821080T (pt) 2018-12-17
LT4005588T (lt) 2024-03-25
SI3195875T1 (sl) 2018-11-30
RS58198B1 (sr) 2019-03-29
HUE027674T2 (en) 2016-11-28
EP3756681A1 (en) 2020-12-30
KR20190140098A (ko) 2019-12-18
HK1204923A1 (en) 2015-12-11
PL3195875T3 (pl) 2019-01-31
EP3646881A1 (en) 2020-05-06
AR087476A1 (es) 2014-03-26
US10624953B2 (en) 2020-04-21
RU2017106756A (ru) 2019-01-23
BR112014002884A2 (pt) 2017-02-21
CN107281470A (zh) 2017-10-24
LT3395357T (lt) 2019-08-26
KR20210143934A (ko) 2021-11-29
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
EP3395357A1 (en) 2018-10-31
EP3756681B1 (en) 2023-05-03
DK3395357T3 (da) 2019-08-19
AU2018203222A1 (en) 2018-05-24
KR102353144B1 (ko) 2022-01-18
AU2016273925A1 (en) 2017-01-12
KR20210099162A (ko) 2021-08-11
EP4306174A2 (en) 2024-01-17
FI4005588T3 (fi) 2024-05-15
JP6161609B2 (ja) 2017-07-12
RU2739037C2 (ru) 2020-12-21
US20200345814A1 (en) 2020-11-05
RU2613324C2 (ru) 2017-03-15
HRP20240420T1 (hr) 2024-06-21
HRP20160145T1 (hr) 2016-04-08
US20180028620A1 (en) 2018-02-01
ES2704878T3 (es) 2019-03-20
TW201309322A (zh) 2013-03-01
SI3566712T1 (sl) 2021-04-30
TR201900071T4 (tr) 2019-01-21
RS64328B1 (sr) 2023-08-31
DK2821080T3 (en) 2019-01-28
DK4005588T3 (da) 2024-04-29
LT3195875T (lt) 2018-11-12
EP4005588A1 (en) 2022-06-01
PL2821080T3 (pl) 2019-04-30
PL2741763T3 (pl) 2016-07-29
JP2014522871A (ja) 2014-09-08
SI3756681T1 (sl) 2023-08-31
HRP20230607T1 (hr) 2023-09-29
BR122020001644B1 (pt) 2022-08-02
AU2012293647A1 (en) 2014-02-27
AU2016273925B2 (en) 2018-03-15
ES2692774T3 (es) 2018-12-05
AU2012293647B2 (en) 2016-10-06
JO3092B1 (ar) 2017-03-15
KR102111514B1 (ko) 2020-05-18
SI3395357T1 (sl) 2019-09-30
LT3566712T (lt) 2021-03-10
KR102014469B1 (ko) 2019-08-26
PL3756681T3 (pl) 2023-08-21
LT3646881T (lt) 2021-05-25
RS54561B1 (en) 2016-06-30
EP3195875A1 (en) 2017-07-26
EP3395357B1 (en) 2019-05-15
EP4005588B1 (en) 2024-02-07
ES2742163T3 (es) 2020-02-13
KR20140054191A (ko) 2014-05-08
ES2562648T3 (es) 2016-03-07
RS59107B1 (sr) 2019-09-30
DK2741763T3 (da) 2016-02-15
KR102499969B1 (ko) 2023-02-14
HRP20210722T1 (hr) 2021-06-11
US20140329748A1 (en) 2014-11-06
PL3566712T3 (pl) 2021-07-12
ES2884947T3 (es) 2021-12-13
EP3566712A1 (en) 2019-11-13
IL230696A0 (en) 2014-03-31
TWI657822B (zh) 2019-05-01
PL3646881T3 (pl) 2021-11-02
PL4005588T3 (pl) 2024-06-10
EP3566712B1 (en) 2021-01-27
TWI555530B (zh) 2016-11-01
KR20230024442A (ko) 2023-02-20
AU2018203222B2 (en) 2020-03-12
EP4306174A3 (en) 2024-04-10
RS61672B1 (sr) 2021-04-29
ES2950911T3 (es) 2023-10-16
SI2741763T1 (sl) 2016-02-29
HRP20181639T1 (hr) 2018-12-14
KR20200121918A (ko) 2020-10-26
DK3566712T3 (da) 2021-04-19
DK3195875T3 (en) 2018-11-12
ES2871405T3 (es) 2021-10-28
SI2821080T1 (sl) 2019-01-31

Similar Documents

Publication Publication Date Title
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika